Skip to search formSkip to main contentSkip to account menu

bleomycin/cyclophosphamide/doxorubicin/prednisone/vincristine protocol

Known as: CA-BOP, CHOP-B, BLEO/CTX/DOX/PRED/VCR 
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, prednisone, and vincristine.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Treatment for patients with stage IV indolent lymphoma ranges from watchful waiting to intensive chemotherapy and stem cell… 
2002
2002
Anthracyclines remain as the best drugs in the treatment of patients with aggressive malignant lymphoma in combination with other… 
1994
1994
Four of 12 Chinese patients receiving BACOP, in combination with recombinant human granulocyte colony-stimulating factor, for… 
1987
1987
Six weeks after receiving a total dose of 20 units of bleomycin sulfate as part of BACOP therapy for non-Hodgkin's lymphoma, our… 
1984
1984
In 1976 we began a randomized study for the treatment of patients with stage III and IV diffuse histiocytic lymphoma. The therapy… 
1982
1982
Two combination chemotherapy programs, ACOMLA (doxorubicin, cyclophosphamide, vincristine, methotrexate and leucovorin rescue… 
Review
1978
Review
1978
A multiplicity of antineoplastic agents are active in the treatment of non‐Hodgkin's lymphomas. In addition to a high order of… 
Highly Cited
1977
Highly Cited
1977
Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine…